Metraipolis › archive › dc_6e16872eb782

Biofluid-derived exosomes as next-generation biotherapeutic platforms to combat multidrug-resistant bacterial infections — Europe PMC PMID:42494840

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42494840
DOI
10.1093/rb/rbag137
License (as archived)
solo-consultazione
Archived
2026-10-19T07:47:25.684Z
SHA-256 of the archived text
d1769753f95e20d58f8d7ede736871b603495f5ae5c5703ce1ee815c3e1669c9
Stable URL of this page
https://metraipolis.com/documento/dc_6e16872eb782

How to cite

Biofluid-derived exosomes as next-generation biotherapeutic platforms to combat multidrug-resistant bacterial infections — Europe PMC PMID:42494840 — Europe PMC (en), https://europepmc.org/article/MED/42494840 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e16872eb782 (Metraipolis archive dc_6e16872eb782, sha256 d1769753f95e20d58f8d7ede736871b603495f5ae5c5703ce1ee815c3e1669c9)
BibTeX
@misc{dc6e16872eb782,
  title = {Biofluid-derived exosomes as next-generation biotherapeutic platforms to combat multidrug-resistant bacterial infections — Europe PMC PMID:42494840},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42494840},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e16872eb782; sha256 d1769753f95e20d58f8d7ede736871b603495f5ae5c5703ce1ee815c3e1669c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42494840. Agents can read the archived copy with the MCP tool read_document.